The Pathogenesis and Management of Achalasia: Current Status and Future Directions

키워드

참고문헌 (130)

1. Sadowski DC, "Achalasia: incidence, prevalence and survival. A population-based study", Neurogastroenterol Motil, 22, pp.e256~e261 (2010)
2. Gockel HR, "Achalasia: will genetic studies provide insights?", Hum Genet, 128, pp.353~364 (2010)
3. Vaezi MF, "Diagnosis and management of achalasia: American College of Gastroenterology Practice Parameter Committee", Am J Gastroenterol, 94, pp.3406~3412 (1999)
4. Francis DL, "Achalasia: update on the disease and its treatment", Gastroenterology, 139, pp.369~374 (2010)
5. Eckardt AJ, "Treatment and surveillance strategies in achalasia: an update", Nat Rev Gastroenterol Hepatol, 8, pp.311~319 (2011)
6. Richter JE, "Management of achalasia: surgery or pneumatic dilation", Gut, 60, pp.869~876 (2011)
7. Spechler SJ, "Classification of oesophageal motility abnormalities", Gut, 49, pp.145~151 (2001)
8. Richter JE, "The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult", Clin Gastroenterol Hepatol, 9, pp.1010~1011 (2011)
9. Kessing BF, "Erroneous diagnosis of gastroesophageal reflux disease in achalasia", Clin Gastroenterol Hepatol, 9, pp.1020~1024 (2011)
10. Katz PO, "Guidelines for the diagnosis and management of gastroesophageal reflux disease", Am J GastroenPatientterol, 108, pp.308~328 (2013)
11. Tucker HJ, "Achalasia secondary to carcinoma: manometric and clinical features", Ann Intern Med, 89, pp.315~318 (1978)
12. Rozman RW Jr, "Features distinguishing secondary achalasia from primary achalasia", Am J Gastroenterol, 85, pp.1327~1330 (1990)
13. Birgisson S, "Achalasia: what’s new in diagnosis and treatment?", Dig Dis, 15(1), pp.1~27 (1997)
14. Paterson WG, "Etiology and pathogenesis of achalasia", Gastrointest Endosc Clin N Am, 11, pp.249~266 (2001)
15. Bieger D, "Viscerotopic representation of the upper alimentary tract in the medulla oblongata in the rat: the nucleus ambiguus", J Comp Neurol, 262, pp.546~562 (1987)
16. Toyama T, "Effects of hexamethonium and other ganglionic blocking agents on electrical activity of the esophagus induced by vagal stimulation in the dog", Eur J Pharmacol, 31, pp.63~71 (1975)
17. Collman PI, "The central vagal efferent supply to the esophagus and lower esophageal sphincter of the cat", Gastroenterology, 104, pp.1430~1438 (1993)
18. Goyal RK, "Nature of the vagal inhibitory innervation to the lower esophageal sphincter", J Clin Invest, 55, pp.1119~1126 (1975)
19. Goyal RK, "VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones", Nature, 288, pp.378~380 (1980)
20. Yamato S, "Role of nitric oxide in esophageal peristalsis in the opossum", Gastroenterology, 103, pp.197~204 (1992)
21. Crist J, "Intramural mechanism of esophageal peristalsis: roles of cholinergic and noncholinergic nerves", Proc Natl Acad Sci U S A, 81, pp.3595~3599 (1984)
22. Aggestrup S, "Regulatory peptides in the lower esophageal sphincter of man", Regul Pept, 10, pp.167~178 (1985)
23. Mearin F, "Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction", Eur J Clin Invest, 23, pp.724~728 (1993)
24. Kimura K, "The nature of idiopathic esophagus dilatation", Jpn J Gastroenterol, 1, pp.199~ (1929)
25. Cassella RR, "Achalasia of the esophagus: pathologic and etiologic considerations", Ann Surg, 160, pp.474~487 (1964)
26. Higgs B, "The experimental production of esophageal achalasia by electrolytic lesions in the medulla", J Thorac Cardiovasc Surg, 50, pp.613~625 (1965)
27. Cassella RR, "Fine-structure changes in achalasia of the esophagus. I. vagus nerves", Am J Pathol, 46, pp.279~288 (1965)
28. Duntemann TJ, "Achalasia-like syndrome presenting after highly selective vagotomy", Dig Dis Sci, 40, pp.2081~2083 (1995)
29. Atkinson M, "Vagal function in achalasia of the cardia", Q J Med, 63, pp.297~303 (1987)
30. Eckardt VF, "Gastrointestinal transit and gastric acid secretion in patients with achalasia", Dig Dis Sci, 34, pp.665~671 (1989)
31. Khajanchee YS, "Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia", J Gastrointest Surg, 7, pp.843~849 (2003)
32. Holloway RH, "Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia", Gastroenterology, 90, pp.924~929 (1986)
33. Greaves RR, "Early experience with intrasphincteric botulinum toxin in the treatment of achalasia", Aliment Pharmacol Ther, 13, pp.1221~1225 (1999)
34. Dodds WJ, "Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia", Gastroenterology, 80, pp.327~333 (1981)
35. Biancani P, "Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation", J Clin Invest, 73, pp.963~967 (1984)
36. Rattan S, "The non-adrenergic non-cholinergic innervation of the esophagus and the lower esophageal sphincter", Arch Int Pharmacodyn Ther, 280(2), pp.62~83 (1986)
37. Rattan S, "Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter", J Pharmacol Exp Ther, 248, pp.703~709 (1989)
38. Rattan S, "Effect of vasoactive intestinal polypeptide", Proc Soc Exp Biol Med, 155, pp.40~43 (1977)
39. Guelrud M, "The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia", Gastroenterology, 103, pp.377~382 (1992)
40. Uddman R, "Peptidergic (VIP) innervation of the esophagus", Gastroenterology, 75, pp.5~8 (1978)
41. Wattchow DA, "Distributions of neuropeptides in the human esophagus", Gastroenterology, 93, pp.1363~1371 (1987)
42. Aggestrup S, "Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia", Gastroenterology, 84(5), pp.924~927 (1983)
43. Sigala S, "Different neurotransmitter systems are involved in the development of esophageal achalasia", Life Sci, 56, pp.1311~1320 (1995)
44. Wattchow DA, "Distribution of peptide-containing nerve fibres in achalasia of the oesophagus", J Gastroenterol Hepatol, 11, pp.478~485 (1996)
45. Tøttrup A, "Nitric oxide mediating NANC inhibition in opossum lower esophageal sphincter", Am J Physiol, 260(3), pp.G385~G389 (1991)
46. Murray J, "Nitric oxide:mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle", Am J Physiol, 261(3), pp.G401~G406 (1991)
47. Conklin JL, "Characterization and mediation of inhibitory junction potentials from opossum lower esophageal sphincter", Gastroenterology, 104, pp.1439~1444 (1993)
48. Fang S, "Distribution of NADPH diaphorase in intramural plexuses of cat and opossum esophagus", J Auton Nerv Syst, 46, pp.123~133 (1994)
49. Murray J, "Nerve-mediated nitric oxide production by opossum lower esophageal sphincter", Dig Dis Sci, 39, pp.1872~1876 (1994)
50. Murray JA, "Characterization of nitric oxide synthase in the opossum esophagus", Gastroenterology, 106, pp.1444~1450 (1994)
51. Gaumnitz EA, "Electrophysiological and pharmacological responses of chronically denervated lower esophageal sphincter of the opossum", Gastroenterology, 109, pp.789~799 (1995)
52. Kim CD, "Neuronal NOS provides nitrergic inhibitory neurotransmitter in mouse lower esophageal sphincter", Am J Physiol, 277(2), pp.G280~G284 (1999)
53. Paterson WG, "Pharmacological characterization of lower esophageal sphincter relaxation induced by swallowing, vagal efferent nerve stimulation, and esophageal distention", Can J Physiol Pharmacol, 70, pp.1011~1015 (1992)
54. Sivarao DV, "Lower esophageal sphincter is achalasic in nNOS(-", -) and hypotensive in W, Gastroenterology, pp.2001, 121[DOI]
55. De Giorgio R, "Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia", Am J Gastroenterol, 94, pp.2357~2362 (1999)
56. Murray JA, "The effects of recombinant human hemoglobin on esophageal motor functions in humans", Gastroenterology, 109, pp.1241~1248 (1995)
57. Singaram C, "Nitrinergic and peptidergic innervation of the human oesophagus", Gut, 35, pp.1690~1696 (1994)
58. Csendes A, "Histological studies of Auerbach’s plexuses of the oesophagus, stomach, jejunum, and colon in patients with achalasia of the oesophagus: correlation with gastric acid secretion, presence of parietal cells and gastric emptying of solids", Gut, 33, pp.150~154 (1992)
59. Frieling T, "Family occurrence of achalasia and diffuse spasm of the oesophagus", Gut, 29, pp.1595~1602 (1988)
60. Stein DT, "Achalasia in monozygotic twins", Dig Dis Sci, 27, pp.636~640 (1982)
61. Annese V, "Family occurrence of achalasia", J Clin Gastroenterol, 20, pp.329~330 (1995)
62. Bosher LP, "Achalasia in siblings: clinical and genetic aspects", Am J Dis Child, 135, pp.709~710 (1981)
63. Park W, "Etiology and pathogenesis of achalasia: the current understanding", Am J Gastroenterol, 100, pp.1404~1414 (2005)
64. Jones DB, "Preliminary report of an association between measles virus and achalasia", J Clin Pathol, 36, pp.655~657 (1983)
65. Robertson CS, "Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia", Gut, 34, pp.299~302 (1993)
66. Niwamoto H, "Are human herpes viruses or measles virus associated with esophageal achalasia?", Dig Dis Sci, 40, pp.859~864 (1995)
67. Birgisson S, "Achalasia is not associated with measles or known herpes and human papilloma viruses", Dig Dis Sci, 42, pp.300~306 (1997)
68. de Oliveira RB, "The spectrum of esophageal motor disorders in Chagas’ disease", Am J Gastroenterol, 90, pp.1119~1124 (1995)
69. Storch WB, "Autoantibodies to Auerbach’s plexus in achalasia", Cell Mol Biol, 41, pp.1033~1038 (1995)
70. Verne GN, "Anti-myenteric neuronal antibodies in patients with achalasia: a prospective study", Dig Dis Sci, 42, pp.307~313 (1997)
71. Moses PL, "Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease", Gut, 52, pp.629~636 (2003)
72. Raymond L, "Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach’s plexus", Histopathology, 35, pp.445~453 (1999)
73. Clark SB, "The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis", Am J Surg Pathol, 24, pp.1153~1158 (2000)
74. Wong RK, "Significant DQw1 association in achalasia", Dig Dis Sci, 34, pp.349~352 (1989)
75. De la Concha EG, "Contribution of HLA class II genes to susceptibility in achalasia", Tissue Antigens, 52, pp.381~384 (1998)
76. Verne GN, "Association of HLA-DR and -DQ alleles with idiopathic achalasia", Gastroenterology, 117, pp.26~31 (1999)
77. Ruiz-de-León A, "Myenteric antiplexus antibodies and class II HLA in achalasia", Dig Dis Sci, 47, pp.15~19 (2002)
78. Gockel I, "Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia", Nat Genet, 46, pp.901~904 (2014)
79. Howard PJ, "Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh", Gut, 33, pp.1011~1015 (1992)
80. Pandolfino JE, "AGA technical review on the clinical use of esophageal manometry", Gastroenterology, 128, pp.209~224 (2005)
81. Pandolfino JE, "AGA technical review on the clinical use of esophageal manometry", Gastroenterology, 128, pp.209~224 (2005)
82. Salvador R, "The preoperative manometric pattern predicts the outcome of surgical treatment for esophageal achalasia", J Gastrointest Surg, 14, pp.1635~1645 (2010)
83. Nitesh Pratap, "Can Achalasia Subtyping by High-Resolution Manometry Predict the Therapeutic Outcome of Pneumatic Balloon Dilatation?: Author’s Reply", Journal of Neurogastroenterology and Motility (JNM), 17(2), pp.205~205 (2011), 대한소화기 기능성질환∙운동학회
84. de Oliveira JM, "Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia", AJR Am J Roentgenol, 169, pp.473~479 (1997)
85. Vaezi MF, "Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram", Am J Gastroenterol, 94, pp.1802~1807 (1999)
86. Vaezi MF, "Assessment of esophageal emptying post-pneumatic dilation: use of the timed barium esophagram", Am J Gastroenterol, 94, pp.1802~1807 (1999)
87. Andersson M, "Evaluation of the response to treatment in patients with idiopathic achalasia by the timed barium esophagogram: results from a randomized clinical trial", Dis Esophagus, 22, pp.264~273 (2009)
88. Dodds WJ, "Radiologic amyl nitrite test for distinguishing pseudoachalasia from idiopathic achalasia", AJR Am J Roentgenol, 146, pp.21~23 (1986)
89. Kahrilas PJ, "Comparison of pseudoachalasia and achalasia", Am J Med, 82, pp.439~446 (1987)
90. Scherer JR, "Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia", J Gastrointest Surg, 13, pp.2219~2225 (2009)
91. Sandler RS, "Failure of clinical criteria to distinguish between primary achalasia and achalasia secondary to tumor", Dig Dis Sci, 27, pp.209~213 (1982)
92. Vaezi MF, "ACG clinical guideline: diagnosis and management of achalasia", Am J Gastroenterol, 108, pp.1238~1249 (2013)
93. Boeckxstaens GE, "Achalasia", Lancet, 383, pp.83~93 (2014)
94. Vaezi MF, "Current therapies for achalasia: comparison and efficacy", J Clin Gastroenterol, 27, pp.21~35 (1998)
95. Lambroza A, "Pneumatic dilation for achalasia without fluoroscopic guidance: safety and efficacy", Am J Gastroenterol, 90, pp.1226~1229 (1995)
96. Thomas V, "Pneumatic dilation of achalasia cardia under direct endoscopy: the debate continues", Gastrointest Endosc, 63, pp.734~ (2006)
97. Lynch KL, "Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature", Am J Gastroenterol, 107, pp.1817~1825 (2012)
98. Ott DJ, "Radiographic evaluation of esophagus immediately after pneumatic dilatation for achalasia", Dig Dis Sci, 32, pp.962~967 (1987)
99. Vela MF, "The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia", Clin Gastroenterol Hepatol, 4, pp.580~587 (2006)
100. Campos GM, "Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis", Ann Surg, 249, pp.45~57 (2009)
101. Gideon RM, "Prospective randomized comparison of pneumatic dilatation technique in patients with idiopathic achalasia", Dig Dis Sci, 44, pp.1853~1857 (1999)
102. Hulselmans M, "Long-term outcome of pneumatic dilation in the treatment of achalasia", Clin Gastroenterol Hepatol, 8, pp.30~35 (2010)
103. Farhoomand K, "Predictors of outcome of pneumatic dilation in achalasia", Clin Gastroenterol Hepatol, 2, pp.389~394 (2004)
104. Eckardt VF, "Predictors of outcome in patients with achalasia treated by pneumatic dilation", Gastroenterology, 103, pp.1732~1738 (1992)
105. Nitesh Pratap, "Achalasia Cardia Subtyping by High-Resolution Manometry Predicts the Therapeutic Outcome of Pneumatic Balloon Dilatation", Journal of Neurogastroenterology and Motility (JNM), 17(1), pp.48~53 (2011), 대한소화기 기능성질환∙운동학회
106. Guardino JM, "Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy", J Clin Gastroenterol, 38, pp.855~860 (2004)
107. Eckardt VF, "Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study", Gastrointest Endosc, 45, pp.349~353 (1997)
108. Ali A, "Laparoscopic myotomy: technique and efficacy in treating achalasia", Gastrointest Endosc Clin N Am, 11, pp.347~358 (2001)
109. Morino M, "Preoperative pneumatic dilatation represents a risk factor for laparoscopic Heller myotomy", Surg Endosc, 11, pp.359~361 (1997)
110. Richards WO, "Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial", Ann Surg, 240, pp.405~412 (2004)
111. Torquati A, "Laparoscopic myotomy for achalasia: predictors of successful outcome after 200 cases", Ann Surg, 243, pp.587~591 (2006)
112. Stefanidis D, "SAGES guidelines for the surgical treatment of esophageal achalasia", Surg Endosc, 26, pp.296~311 (2012)
113. Rawlings A, "Laparoscopic Dor versus Toupet fundoplication following Heller myotomy for achalasia: results of a multicenter, prospective, randomized-controlled trial", Surg Endosc, 26, pp.18~26 (2012)
114. Boeckxstaens GE, "Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia", N Engl J Med, 364, pp.1807~1816 (2011)
115. Sweet MP, "The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation", J Gastrointest Surg, 12, pp.159~165 (2008)
116. Mineo TC, "Long-term results and quality of life after surgery for oesophageal achalasia: one surgeon’s experience", Eur J Cardiothorac Surg, 25, pp.1089~1096 (2004)
117. Glatz SM, "Esophagectomy for end stage achalasia", J Gastrointest Surg, 11, pp.1134~1137 (2007)
118. Kadakia SC, "Pneumatic balloon dilation for esophageal achalasia", Gastrointest Endosc Clin N Am, 11, pp.325~346 (2001)
119. Inoue H, "Peroral endoscopic myotomy (POEM) for esophageal achalasia", Endoscopy, 42, pp.265~271 (2010)
120. Inoue H, "Per-oral endoscopic myotomy (POEM) for 43 consecutive cases of esophageal achalasia", Nihon Rinsho, 68, pp.1749~1752 (2010)
121. von Renteln D, "Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study", Am J Gastroenterol, 107, pp.411~417 (2012)
122. Swanström LL, "A stepwise approach and early clinical experience in peroral endoscopic myotomy for the treatment of achalasia and esophageal motility disorders", J Am Coll Surg, 213, pp.751~756 (2011)
123. Orenstein SB, "Peroral endoscopic myotomy (POEM) leads to similar results in patients with and without prior endoscopic or surgical therapy", Surg Endosc, 29, pp.1064~1070 (2015)
124. Bhayani NH, "A comparative study on comprehensive, objective outcomes of laparoscopic Heller myotomy with per-oral endoscopic myotomy (POEM) for achalasia", Ann Surg, 259, pp.1098~1103 (2014)
125. Sandler RS, "The risk of esophageal cancer in patients with achalasia: a population-based study", JAMA, 274, pp.1359~1362 (1995)
126. Leeuwenburgh I, "Long-term esophageal cancer risk in patients with primary achalasia: a prospective study", Am J Gastroenterol, 105, pp.2144~2149 (2010)
127. Bonatti H, "Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia", Am J Surg, 190, pp.874~878 (2005)
128. Costantini M, "The laparoscopic Heller-Dor operation remains an effective treatment for esophageal achalasia at a minimum 6-year follow-up", Surg Endosc, 19, pp.345~351 (2005)
129. Zerbib F, "Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia", Am J Gastroenterol, 101, pp.692~697 (2006)
130. Eckardt VF, "Life expectancy, complications, and causes of death in patients with achalasia: results of a 33-year follow-up investigation", Eur J Gastroenterol Hepatol, 20, pp.956~960 (2008)

관련 논문AI추천